A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis
Clinical trial NCT02696785 · COMPLETED
Trial details
- NCT number
- NCT02696785
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-02
- Primary completion
- 2017-12-08
- Enrollment
- 341
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.